EASTON BIOPHARMACEUTICALS: The hydrochloride ephedrine tablets have obtained a drug registration certificate
EASTON BIOPHARMACEUTICALS' wholly-owned subsidiary Chengdu ShuoDe Pharmaceutical recently obtained the "Drug Registration Certificate" issued by the National Medical Products Administration, with the drug name being Etifoxine Hydrochloride Tablets. This medication is primarily used to improve muscle tension states in conditions such as cervical shoulder-arm syndrome, shoulder periarthritis, and low back pain, as well as spastic paralysis caused by various brain and spinal cord diseases
According to the Zhitong Finance APP, EASTON BIOPHARMACEUTICALS (688513.SH) announced that its wholly-owned subsidiary Chengdu ShuoDe Pharmaceutical Co., Ltd. (referred to as "ShuoDe Pharmaceutical") recently received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration, with the drug name: Hydrochloride Eperisone Tablets.
The main active ingredient of Hydrochloride Eperisone Tablets is Hydrochloride Eperisone, and the main indications are: to improve muscle tension states in conditions such as cervical, shoulder, and arm syndrome, periarthritis of the shoulder, and low back pain; cerebrovascular disorders, spastic spinal paralysis, cervical spondylosis, postoperative sequelae (including brain and spinal cord tumors), sequelae of trauma (spinal cord injury, head injury), amyotrophic lateral sclerosis, infantile cerebral palsy, spinal cerebellar degeneration, spinal vascular disorders, subacute optic neuritis myelitis (SMON), and other spastic paralysis caused by brain and spinal cord diseases
